FDA Webview
X

Free FDA Notices

Guidance on Human Factor Studies for Combo Products

02/03/2016

Federal Register Notice: FDA is making available a draft guidance for industry and FDA staff entitled Human Factors Studies and Related Clinical Study Considerations in Combination Product Design and Development. It provides guidance on the underlying principles of human factors studies during the development of combination products. To download this draft guidance, click here. To view this notice, click here.

LATEST NEWS